Remedium’s Hemogrip Snags FDA Clearance

July 16, 2015

Remedium Technologies has gained FDA 510(k) clearance to market its first product, the Hemogrip patch for the treatment of uncontrolled hemorrhage.

The patch controls bleeding occurring from the access of veins or arteries during medical treatment, the company said Wednesday. The product relies on chitosan, a natural polymer found in the exoskeleton of crustaceans, to generate a mesh capable of coagulating blood.

The company has other bleeding control products in the pipeline, including a clear transparent film, hemostatic gauze and sprayable foam, a spokesman told Device Daily Thursday.

Based at the University of Maryland, Remedium has received funding from the National Science Foundation, the United States Army Research Lab, the Maryland Industrial Partnerships, the Maryland Biotechnology Center and Tedco.

The devicemaker is seeking CE Mark certification. — Jason Scott